Close

Wynyard theatre gets $5m boost

Plans to build a new theatre at Wynyard Quarter got a boost today in the form of a $5 million ASB Community Trust pledge.

Plans to build a new theatre at Wynyard Quarter got a boost today in the form of a $5 million ASB Community Trust pledge.

That brings the total pledged to $21.7 million; the total amount needed to build the new 600-seat venue is $35.1 million.

The Auckland Theatre Company will be the anchor tenant and the driving force behind the development.

ASB Community Trust chair Ken Whitney said: "Large scale projects such as this inevitably require a number of funding partners to work together collaboratively to realise a shared vision. 

"In a relatively short time this approach has endowed our city with a number of iconic buildings such as the magnificently refurbished art gallery, Q Theatre, the Eden Park stadium redevelopment, the extensions to the War Memorial Museum, MOTAT and the Auckland Zoo, to name a few.  The ASBCT has made a significant contribution to each of these projects and we are excited to be an early key funder for the ATC's stunning new theatre here in the Wynyard Quarter." 

The new theatre will be located on the corner of Halsey St and Jellicoe S. alongside ASB's new office building

It will be designed by Moller Architects in association with Bligh Voller Nield, and share a public lane way, courtyard and studio theatre with ASB, which is a cornerstone partner of the project.

 ASB has already pledged $6 million towards shared building costs.

Idealog has been covering the most interesting people, businesses and issues from the fields of innovation, design, technology and urban development for over 12 years. And we're asking for your support so we can keep telling those stories, inspire more entrepreneurs to start their own businesses and keep pushing New Zealand forward. Give over $5 a month and you will not only be supporting New Zealand innovation, but you’ll also receive a print subscription and a copy of the new book by David Downs and Dr. Michelle Dickinson, No. 8 Recharged (while stocks last).